Boserolimab

Synonyms

Boserolimab, Anti-CD27 Agonist Monoclonal Antibody MK-5890, Anti-CD27 Agonistic Monoclonal Antibody MK-5890, BOSEROLIMAB, MK 5890, MK-5890, MK5890

Thesaurus

A humanized agonistic monoclonal antibody targeting the cell surface antigen CD27, with potential immunostimulatory and antineoplastic activities. Upon administration, boserolimab targets and binds to CD27 on a variety of immune cell types, including most T-lymphocytes. This induces CD27-dependent signaling pathways and enhances T-cell-mediated responses, including the expansion of antigen-activated T-cells and the cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells. CD27, a co-stimulatory molecule and member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on T-lymphocytes, memory B-cells and natural killer (NK) cells. It plays an important role in NK cell-mediated cytolytic activity and T- and B-lymphocyte proliferation and activation. It is overexpressed in certain tumor cell types. Boserolimab, Amino Acid, Peptide, or Protein, Pharmacologic Substance

• NCI Thesaurus (external)

C20401.

This concise article on Boserolimab incorporates public domain text from the US National Library of Medicine.

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.